Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
1.810
-0.030 (-1.63%)
At close: May 7, 2024, 4:00 PM
1.850
+0.040 (2.21%)
After-hours: May 7, 2024, 6:23 PM EDT
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SNSE stock has a target of 4.00, which predicts an increase of 120.99% from the current stock price of 1.81.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 4, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for SNSE is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +120.99% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +231.49% | Dec 13, 2022 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +176.24% | Oct 3, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +452.49% | Mar 10, 2022 |
| Berenberg | Berenberg | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.03
from -1.22
EPS Next Year
-1.07
from -1.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.68 | -0.91 | -0.49 |
| Avg | -1.03 | -1.07 | -0.89 |
| Low | -1.26 | -1.18 | -1.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.